Su MY - Search Results

1

Prediction of breast cancer molecular subtypes on DCE-MRI using convolutional neural network with transfer learning between two centers.

Zhang Y, Chen JH, Lin Y, Chan S, Zhou J, Chow D, Chang P, Kwong T, Yeh DC, Wang X, Parajuli R, Mehta RS, Wang M, Su MY. Zhang Y, et al. Among authors: su my. Eur Radiol. 2021 Apr;31(4):2559-2567. doi: 10.1007/s00330-020-07274-x. Epub 2020 Oct 1. Eur Radiol. 2021. PMID: 33001309 Free PMC article.

2

Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.

Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. Su MY, et al. Technol Cancer Res Treat. 2002 Dec;1(6):479-88. doi: 10.1177/153303460200100608. Technol Cancer Res Treat. 2002. PMID: 12625775 Free article.

3

Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer.

Hsiang D, Shah N, Yu H, Su MY, Cerussi A, Butler J, Baick C, Mehta R, Nalcioglu O, Tromberg B. Hsiang D, et al. Among authors: su my. Technol Cancer Res Treat. 2005 Oct;4(5):549-58. doi: 10.1177/153303460500400508. Technol Cancer Res Treat. 2005. PMID: 16173825 Free article.

4

Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.

Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. Baik HM, et al. Among authors: su my. MAGMA. 2006 May;19(2):96-104. doi: 10.1007/s10334-006-0032-4. Epub 2006 May 9. MAGMA. 2006. PMID: 16779565

5

Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.

Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. Su MY, et al. Technol Cancer Res Treat. 2006 Aug;5(4):401-10. Technol Cancer Res Treat. 2006. PMID: 16866570

6

Mild cognitive impairment: apparent diffusion coefficient in regional gray matter and white matter structures.

Ray KM, Wang H, Chu Y, Chen YF, Bert A, Hasso AN, Su MY. Ray KM, et al. Among authors: su my. Radiology. 2006 Oct;241(1):197-205. doi: 10.1148/radiol.2411051051. Radiology. 2006. PMID: 16990677

7

Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy.

Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O, Su MY. Agrawal G, et al. Among authors: su my. J Clin Oncol. 2007 Jun 20;25(18):2618-20. doi: 10.1200/JCO.2007.11.3084. J Clin Oncol. 2007. PMID: 17577043 No abstract available.

8

MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.

Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. Yu HJ, et al. Among authors: su my. J Magn Reson Imaging. 2007 Sep;26(3):615-23. doi: 10.1002/jmri.21060. J Magn Reson Imaging. 2007. PMID: 17729334

9

Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.

Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, Butler JA. Hsiang DJ, et al. Among authors: su my. Arch Surg. 2007 Sep;142(9):855-61; discussion 860-1. doi: 10.1001/archsurg.142.9.855. Arch Surg. 2007. PMID: 17875840

10

The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy.

Yamamoto M, Mehta RS, Baick CH, Su MY, Lane KT, Butler JA, Hsiang DJ. Yamamoto M, et al. Among authors: su my. Am Surg. 2007 Oct;73(10):977-80. doi: 10.1177/000313480707301010. Am Surg. 2007. PMID: 17983061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters